Block.one issued a $50,000 grant to decentralized BioBank Genobank for its open-source app on April 29. Genobank announced during April that its app, Agerona, is being developed alongside the Eos-based blockchain platform, Telos.
The grant is designed to facilitate anonymous access to COVID-19 testing.
Block.one issued the grant in partnership with:
- Its venture capital wing, EOS VC
- German fintech incubator FinLab EOS VC
Agerona connects users anonymously with test suppliers in their country. The Tests contain unique barcodes that create a free and anonymous account on the Telos blockchain for the users.
Kits are then sent to a verified lab for processing, with results anonymously uploaded to the blockchain. The system allows for test results to then be analyzed by health researchers, without being tied to the identity of the individuals tested.
Genobank CEO Daniel Uribe stated:
“[W]e are grateful to have the backing and support of Block.one’s venture arm EOS VC in aiding our efforts to anonymize DNA/RNA test kits (including coronavirus) while empowering patients and users to decide if they want their anonymized data to be available to the scientific community and help control the spread of the coronavirus and potentially contribute to a treatment.”
Block.one chief executive Brendan Blumer stated:
“We’ve witnessed the growth of an open-source community whose passion and innovation have helped to identify and solve critical business problems in sectors ranging from art to wellness.”
Block.one has funded several companies working on solutions to problems relating to COVID-19. The recipients include health and wellness platform, PUML Better Health, the job-listing platform, Moonlighting, and the AI service, Innoplexus.
“With the onset of urgent world issues caused by the coronavirus, it is important that we empower and support the ways that blockchain technology is being applied to provide solutions,” stated .